La vendita allo scoperto per Equinor dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Equinor. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Equinor (NYSE:EQNR) Azioni, Report sulle vendite allo scoperto

Equinor

Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2023 (53% liquids) and ended 2023 with 5.2 billion barrels of proven reserves (49% liquids). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.

European stocks

Opinion

Trading Ideas

AGRO

EQNR

STLA

Ecco cinque titoli del Vecchio Continente che, nonostante un mercato in ripresa, rimangono sottovalutati e con buone prospettive di crescita.

5 azioni del Vecchio Continente da mettere nel proprio portafoglio

Equinor ASA

<p><a href="https://x.com/elonmusk/status/1939762942851027127" title="https://x.com/elonmusk/status/1939762942851027127">https://x.com/elonmusk/status/1939762942851027127</a></p>


Macro Economic Events

News

Politics

Economics

General

TSLA

Elon Musk Posts On X "It is obvious with the insane spending of this bill, which increases the debt ceiling by a record FIVE TRILLION DOLLARS that we live in a one-party country – the PORKY PIG PARTY!! Time for a new political party that actually cares about the people."

<p><strong>Reddit Inc.</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) shares are trading higher Monday, continuing a strong run driven by anticipated user growth and <a href="http://v">rising investor optimism</a>.</p>
<p><strong>What To Know:</strong> <a href="https://x.com/Similarweb/status/1939642834245616024?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Etweet">Similarweb</a> on Monday highlighted a surge in app store downloads for Reddit in recent months, noting that adoption appears to be skyrocketing. Download volumes surged 77.98% in April compared to March, followed by another 47.92% month-over-month increase in May. The spike comes after a year of relatively flat app downloads growth.</p>
<p>Shares have also seen strong momentum over the past quarter, gaining more than 44% over the last three months and more than 34% in the past month alone. Reddit is now up more than 127% over the past year, sharply rebounding from early 2025 lows. Its current market cap stands at approximately $26.4 billion, with the stock trading higher on above-average volume. The surge in activity may also be amplified by short covering, with 16.3% of Reddit's float sold short at last check, per <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p>Recent analyst updates suggest the rally could continue. Citigroup last week raised its price target to $163, citing sustained user growth and improving platform engagement. Guggenheim reiterated its $165 target, emphasizing Reddit's expanding monetization potential as it scales. The stock's consensus price target has edged higher, with analysts broadly maintaining a positive outlook.</p>
<p>Looking ahead, investors are focused on Reddit's next earnings release for concrete guidance on how the surge in downloads is translating into revenue. In the company&#8217;s most recent earnings report, Reddit emphasized plans to grow ad offerings, expand partnerships and improve personalization algorithms, all of which could help convert the platform's user momentum into sustained financial performance.</p>
<p><strong>RDDT Price Action: </strong>Reddit shares were up 5.09% at $150.29 at the time of writing Monday, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a></p>
<p><strong>Read Next:</strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/markets/equities/25/06/46175722/stocks-today-us-markets-wallstreet-news">Wall Street Extends Record Highs, Dow Jones Hits 44,000: What&#8217;s Driving Markets Monday?</a></strong></li>
</ul>
<p><em>Image via Shutterstock.</em></p>


Movers

RDDT

Reddit Shares Surge As App Downloads Spike: What's Going On?

<p>Cryptocurrency markets opened the week with sideways price action ahead of Federal Reserve Chair <strong>Jerome Powell</strong>'s speech scheduled for Tuesday.<br /></p>
<p><figure class="wp-block-table"><br />
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Ticker</strong></td>
<td><strong>Price</strong></td>
</tr>
<tr>
<td><strong>Bitcoin</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>$107,285.07</td>
</tr>
<tr>
<td><strong>Ethereum</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>$2,488.00</td>
</tr>
<tr>
<td><strong>Solana</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>$155.89</td>
</tr>
<tr>
<td><strong>XRP</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>$2.22</td>
</tr>
<tr>
<td><strong>Dogecoin</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.1646</td>
</tr>
<tr>
<td><strong>Shiba Inu</strong></td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00001140</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Notable Statistics:</strong></p>
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume decreasing by 6.9% and daily active addresses falling by 10.5%. Transactions greater than $100,000 are up from 7,560 to 7,612 in a single day. Exchanges netflows are down by 613.9%.</li>
<li>Coinglass data reports 94,334 traders were liquidated in the past 24 hours for $251.96 million.</li>
<li>Glassnode data <a href="https://x.com/AltCryptoGems/status/1939735664678838545">shows</a> Bitcoin wallets holding more than $1 million in BTC increased sharply in recent weeks.</li>
</ul>
<p><strong>Notable Developments:</strong></p>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46175268/ethereum-traders-target-4000-in-summer-whats-fueling-the-optimism">Ethereum Traders Target $4,000 In Summer: What&#8217;s Fueling The Optimism?</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46168111/bitcoin-options-traders-shift-bullish-heres-their-strategy-for-q3">Bitcoin Options Traders Shift Bullish: Here&#8217;s Their Strategy For Q3</a></li>
<li><a href="https://www.benzinga.com/crypto/25/06/46174854/robinhood-just-made-crypto-simpler-and-way-more-powerful">Robinhood Just Made Crypto Simpler — And Way More Powerful</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46168953/strategy-adds-4980-bitcoin-ups-total-stack-to-42-billion">Strategy Adds 4,980 Bitcoin, Ups Total Stack To $42 Billion</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46166208/bitcoin-etfs-extend-record-2-2b-net-inflows-to-extend-streak-to-11-weeks">Bitcoin ETFs Extend Record $2.2B Net Inflows To Extend Streak To 11 Weeks</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46169668/barclays-faces-epstein-fallout-as-former-ceo-faces-trial">Barclays Faces Epstein Fallout As Former CEO Faces Trial</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46165366/circle-stock-is-a-must-hold-says-bernstein-heres-why">Circle Stock Is A &#8216;Must Hold,&#8217; Says Bernstein: Here&#8217;s Why</a></li>
</ul>
<p><strong>Top Losers:</strong></p>
<p><figure class="wp-block-table"><br />
<table class="has-fixed-layout">
<tbody>
<tr>
<td><strong>Cryptocurrency</strong></td>
<td><strong>Ticker</strong></td>
<td><strong>Price&nbsp;&nbsp;&nbsp;</strong></td>
</tr>
<tr>
<td>DeXe</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">DEXE</a>)</td>
<td>$7.54</td>
</tr>
<tr>
<td>Maple Finance</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SYRUP</a>)</td>
<td>$0.5575</td>
</tr>
<tr>
<td>Sei</td>
<td>(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">SEI</a>)</td>
<td>$0.2869</td>
</tr>
</tbody>
</table>
<p></p></figure></p>
<p><strong>Trader Notes:  </strong>Crypto trader CryptoCon pointed out that today marks day 195 of sideways Bitcoin price action since Dec. 18, 2024. </p>
<p>Despite the ongoing bull cycle, Bitcoin has spent most of its time in a grinding, non-directional range. </p>
<p>According to him, only 36 days during this stretch have delivered meaningful upside, while the rest have been defined by brutal, slow consolidation.</p>
<p>Zooming out, CryptoCon noted that Bitcoin has now spent over two years in largely directionless movement, with periodic rallies giving the illusion of trend strength—when in reality, the broader structure has been defined by stagnation and new lows.</p>
<p>"You're surviving the slowest overall cycle yet, but it's not finished," he emphasized.</p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">This is day 195 of sideways Bitcoin price action since December 18th of last year.<br /><br />The trend has been simple, but gruesome:<br /><br />All of the great price action has been made in very short bursts, totaling just 36 days. We have now spent a total of 2 years in sideways price action.… <a href="https://t.co/1dbrYRdf6T">pic.twitter.com/1dbrYRdf6T</a></p>
<p>&mdash; CryptoCon (@CryptoCon_) <a href="https://twitter.com/CryptoCon_/status/1939736572725018958?ref_src=twsrc%5Etfw">June 30, 2025</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>Meanwhile, Ted Pillows <a href="https://x.com/TedPillows/status/1939734089122119803">observed</a> that Bitcoin has been consolidating just below its all-time high for over a month. </p>
<p>With the S&amp;P 500 recently breaking to new highs, he believes Bitcoin is primed to follow suit, forecasting a potential breakout above $120,000 to signal the next major leg up.</p>
<p>Javon Marks <a href="https://x.com/JavonTM1/status/1939664986650956101">identified</a> $116,652 as a near-term breakout level. </p>
<p>Current price action just beneath this mark shows bullish signs, and a decisive move above it could ignite a rally to $165,000 or higher, a gain of over 50% from current levels. </p>
<p>He views this as a likely continuation of the broader bull cycle rather than a top formation.</p>
<p><strong>Read Next:&nbsp;</strong></p>
<ul class="wp-block-list">
<li><strong><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46172312/bitcoins-perfect-storm-could-extend-bull-run-into-2026-report">Bitcoin&#8217;s &#8216;Perfect Storm&#8217; Could Extend Bull Run Into 2026: Report</a></strong></li>
</ul>
<p><em>Image: Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$DEXE

$DOGE

$ETH

$SEI

$SHIB

$SOL

$SYRUP

$XRP

Bitcoin Steady, Ethereum, XRP, Dogecoin Turn Green As Traders Bemoan 'The Slowest Cycle Yet'

<p><i>Seeks Damages and Injunctions to Restore its Exclusive Patent Rights</i></p>
<p>TEMPLE, Texas, June 30, 2025 /PRNewswire/ -- Xockets, Inc., a Texas-based pioneer and the inventor of advanced Data Processing Units ("DPUs") that enable accelerated computing and artificial intelligence ("AI") in cloud data centers, today filed two lawsuits against Amazon.com, Inc. and Amazon Web Services in U.S. federal court alleging willful patent infringement. Xockets' patented DPU technologies form the foundation of modern clouds and the AI revolution.</p>
<p>The lawsuits, filed in the U.S. District Court for the Western District of Texas, Austin Division, allege that, for years, Amazon has brazenly infringed Xockets' exclusive patents rights to its DPU innovations—without Xockets' knowledge or permission.</p>
<p>Xockets' patented DPU technologies—or intellectual property—is what Amazon uses to supercharge its cloud computing performance and slash operating costs to stay competitive.</p>
<p>Xockets further alleges that Amazon's Annapurna Labs which designs, develops, and tests Amazon's accused cloud infrastructure in Austin, Texas is "ground zero" for the infringement. The infringement extends throughout Amazon's cloud, including to its compute, AI, and storage server systems, which today include Annapurna Labs' Nitro-branded DPUs integrated with cloud servers using Elastic Fabric Adapters (EFAs) and/or Elastic Network Adapters (ENAs).</p>


AMZN

Xockets Files Two Lawsuits Against Amazon.Com Inc. And Amazon Web Services In U.S. Federal Court Alleging Willful Patent Infringement

WIIM

AIRT

AIRT stock has given up its prior loss. Air T shares were trading lower after the company reported a year-over-year decrease in Q4 financial results.

<p>Burford Capital Limited ("Burford"), the leading global finance and asset management firm focused on law, today issues the following update to its June 17, 2025 statement in connection with proposed tax provisions relating to litigation finance included within the US Senate's draft of the budget reconciliation bill.</p>
<p>In revisions to the bill over the weekend, the proposed tax rate has been reduced to 31.8% (instead of 40.8%) and the withholding tax rate has been reduced to 15.9% of gains (instead of 50% of the tax rate applied to gross proceeds).</p>
<p>In response to those changes, the nonpartisan Joint Committee on Taxation reduced its estimates of the expected tax revenue the provisions could generate over the next decade to $1.4 billion; prior estimates were as high as $3.5 billion.</p>
<p>The Senate continues to debate the legislation, and there remain a number of uncertain procedural and political steps both for the litigation finance provisions and the bill itself before enactment could occur.&nbsp; The outcome of those steps, including the failure to enact the provisions at all, remains unpredictable.&nbsp; Moreover, as discussed in the prior statement, Burford is not yet able to assess the impact of those provisions, if enacted in their current form, on its future tax position.</p>


Burford Capital Issues Update On U.S. Tax Proposal As Litigation Finance Rate Cut To 31.8%

<p><i><strong>PWR delivers science-driven cellular energy and recovery support as part of Jupiter's expanding longevity supplement portfolio</strong></i></p>
<p>Jupiter, Florida, June 30, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JUNS#NASDAQ">JUNS</a>) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL&#x2122;, a patented resveratrol-based platform, is pleased to unveil Nugevia&#x2122; PWR, a daily mitochondrial health supplement scientifically formulated to support cellular energy, endurance, and recovery. PWR targets a rapidly expanding consumer demand for science-backed, clinically validated supplements, providing a high-margin growth opportunity within the longevity and wellness markets, projected to reach $8 trillion by 2030, with commercial availability expected in Fall 2025.</p>


JUNS

Jupiter Neurosciences Unveils Nugevia PWR To Meet Demand For Clinically Validated Longevity Supplements; Commercial Availability Expected In Fall 2025

<p><a href="https://x.com/att/status/1939762407657636274?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg">https://x.com/att/status/1939762407657636274?s=46&amp;t=dtUiyC3dUs5yGRgT9qYHWg</a></p>


AT&T Posts On X "We've reached out to the White House and are working to quickly understand and assess the situation."

TIRX

TIAN RUIXIANG Holdings Completes The Acquisition Of 100% Of Issued And Outstanding Shares Of Ucare; The All-Stock Transaction Valued At $150M

<p><a href="https://www.bloomberg.com/news/articles/2025-06-30/enbridge-line-5-dispute-with-michigan-goes-to-us-supreme-court">https://www.bloomberg.com/news/articles/2025-06-30/enbridge-line-5-dispute-with-michigan-goes-to-us-supreme-court</a></p>


'Enbridge Dispute With Michigan Over Oil Pipeline Goes to US Supreme Court'- Bloomberg

FSLR

First Solar shares are trading higher as investors assess the impacts on the sector from President Donald Trump's new spending bill.

<p>Deep-pocketed investors have adopted a bullish approach towards DoorDash (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NASDAQ">DASH</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DASH usually suggests something big is about to happen.</p>
<p>We gleaned this information from our observations today when Benzinga's options scanner highlighted 23 extraordinary options activities for DoorDash. This level of activity is out of the ordinary.</p>
<p>The general mood among these heavyweight investors is divided, with 47% leaning bullish and 43% bearish. Among these notable options, 7 are puts, totaling $541,282, and 16 are calls, amounting to $1,167,710.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $100.0 to $280.0 for DoorDash during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of DoorDash stands at 3303.47, with a total volume reaching 123,071.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in DoorDash, situated within the strike price corridor from $100.0 to $280.0, throughout the last 30 days.</p>
<h3>DoorDash Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310085_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th align="right"><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$13.7</td>
<td>$13.6</td>
<td>$13.6</td>
<td>$250.00</td>
<td>$342.1K</td>
<td align="right">644</td>
<td align="right">281</td>
</tr>
<tr>
<td>DASH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$81.5</td>
<td>$81.05</td>
<td>$81.5</td>
<td>$175.00</td>
<td>$244.5K</td>
<td align="right">118</td>
<td align="right">30</td>
</tr>
<tr>
<td>DASH</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$30.3</td>
<td>$27.85</td>
<td>$28.11</td>
<td>$230.00</td>
<td>$160.2K</td>
<td align="right">34</td>
<td align="right">62</td>
</tr>
<tr>
<td>DASH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$51.05</td>
<td>$50.55</td>
<td>$51.05</td>
<td>$280.00</td>
<td>$117.4K</td>
<td align="right">0</td>
<td align="right">48</td>
</tr>
<tr>
<td>DASH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$51.0</td>
<td>$50.4</td>
<td>$51.0</td>
<td>$280.00</td>
<td>$91.8K</td>
<td align="right">0</td>
<td align="right">66</td>
</tr>
</tbody>
</table>
</p>
<h3>About DoorDash</h3>
<p>Founded in 2013 and headquartered in San Francisco, DoorDash is an online delivery demand aggregator. Consumers can use its app to order food items on-demand for delivery or in-store from merchants. Through the acquisition of Wolt in 2022, the firm also provides this service in Europe and Asia. DoorDash creates a marketplace for merchants to establish a presence online, market their offerings, and meet demand through delivery. The firm provides similar service to nonrestaurant businesses, such as grocery, retail, and pet supplies. Dash is also rolling out nascent technology like drone delivery in an effort to continually innovate and provide the best possible service to supply-side and demand-side contingents of its marketplace.</p>
<p>Following our analysis of the options activities associated with DoorDash, we pivot to a closer look at the company's own performance.</p>
<h3>Current Position of DoorDash</h3>
<ul>
<li>With a trading volume of 4,884,434, the price of DASH is up by 1.44%, reaching $245.81.</li>
<li>Current RSI values indicate that the stock is may be overbought.</li>
<li>Next earnings report is scheduled for 31 days from now.</li>
</ul>
<h3>Expert Opinions on DoorDash</h3>
<p>In the last month, 5 experts released ratings on this stock with an average target price of $239.6.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on DoorDash with a target price of $245.<br />
&#x2A; Reflecting concerns, an analyst from Stifel lowers its rating to Hold with a new price target of $198.<br />
&#x2A; In a positive move, an analyst from Raymond James has upgraded their rating to Strong Buy and adjusted the price target to $260.<br />
&#x2A; Consistent in their evaluation, an analyst from Cantor Fitzgerald keeps a Overweight rating on DoorDash with a target price of $260.<br />
&#x2A; Consistent in their evaluation, an analyst from JMP Securities keeps a Market Outperform rating on DoorDash with a target price of $235. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest DoorDash options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


Options

Markets

DASH

DoorDash Unusual Options Activity

<p>In the preceding three months, 6 analysts have released ratings for Cencora (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COR#NYSE">COR</a>), presenting a wide array of perspectives from bullish to bearish.</p>
<p>The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>The 12-month price targets, analyzed by analysts, offer insights with an average target of $327.0, a high estimate of $355.00, and a low estimate of $285.00. Witnessing a positive shift, the current average has risen by 11.41% from the previous average price target of $293.50.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310080_0.png" alt="price target chart" /></p>
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
<p>A comprehensive examination of how financial experts perceive Cencora is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jonathan Petersen</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Hold</td>
<td>$300.00</td>
<td>$275.00</td>
</tr>
<tr>
<td>Stephen Baxter</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$337.00</td>
<td>$274.00</td>
</tr>
<tr>
<td>Michael Rollins</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$355.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>David Rodgers</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$350.00</td>
<td>$314.00</td>
</tr>
<tr>
<td>Kevin Caliendo</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$335.00</td>
<td>$298.00</td>
</tr>
<tr>
<td>Michael Funk</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Neutral</td>
<td>$285.00</td>
<td>$270.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Cencora. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Cencora compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Cencora's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Cencora's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/COR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Cencora analyst ratings.</strong></a></p>
<h2>All You Need to Know About Cencora</h2>
<p>Cencora is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.</p>
<h3>Cencora: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Revenue Growth:</strong> Over the 3M period, Cencora showcased positive performance, achieving a revenue growth rate of <strong>10.29%</strong> as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Health Care sector, the company excelled with a growth rate higher than the average among peers.</p>
<p><strong>Net Margin:</strong> Cencora's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>0.95%,</strong> the company showcases strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>115.84%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Cencora's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.02%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>7.76</strong>, Cencora faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

6 Analysts Have This To Say About Cencora

<p>Financial giants have made a conspicuous bearish move on Lululemon Athletica. Our analysis of options history for Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) revealed 48 unusual trades.</p>
<p>Delving into the details, we found 27% of traders were bullish, while 56% showed bearish tendencies. Out of all the trades we spotted, 19 were puts, with a value of $2,299,998, and 29 were calls, valued at $1,956,982.</p>
<h3>What's The Price Target?</h3>
<p>Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $120.0 to $500.0 for Lululemon Athletica during the past quarter. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Lululemon Athletica's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lululemon Athletica's whale trades within a strike price range from $120.0 to $500.0 in the last 30 days. </p>
<h3>Lululemon Athletica Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310080_0_0.png" alt="Options Call Chart" /></p>
<h3>Noteworthy Options Activity:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$6.3</td>
<td>$5.65</td>
<td>$5.8</td>
<td>$220.00</td>
<td>$435.0K</td>
<td>930</td>
<td align="right">774</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$21.4</td>
<td>$18.2</td>
<td>$21.0</td>
<td>$200.00</td>
<td>$420.0K</td>
<td>595</td>
<td align="right">201</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$12.2</td>
<td>$11.85</td>
<td>$11.95</td>
<td>$240.00</td>
<td>$180.4K</td>
<td>1.8K</td>
<td align="right">801</td>
</tr>
<tr>
<td>LULU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$44.8</td>
<td>$43.45</td>
<td>$43.55</td>
<td>$240.00</td>
<td>$178.2K</td>
<td>233</td>
<td align="right">116</td>
</tr>
<tr>
<td>LULU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$16.3</td>
<td>$15.45</td>
<td>$15.45</td>
<td>$185.00</td>
<td>$169.9K</td>
<td>84</td>
<td align="right">115</td>
</tr>
</tbody>
</table>
</p>
<h3>About Lululemon Athletica</h3>
<p>Lululemon Athletica designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. The company offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. Lululemon also sells fitness accessories, such as bags, yoga mats, and equipment. It sells its products through digital channels, a small number of wholesale partners, more than 760 company-owned stores in about two dozen countries in North America, Asia, and Western Europe, and about 40 franchised locations in the Middle East. The company was founded in 1998 and is based in Vancouver, Canada.</p>
<p>In light of the recent options history for Lululemon Athletica, it's now appropriate to focus on the company itself. We aim to explore its current performance.</p>
<h3>Lululemon Athletica's Current Market Status</h3>
<ul>
<li>With a volume of 1,952,459, the price of LULU is down 0.0% at $235.01. </li>
<li>RSI indicators hint that the underlying stock may be oversold.</li>
<li>Next earnings are expected to be released in 59 days.</li>
</ul>
<h3>Professional Analyst Ratings for Lululemon Athletica</h3>
<p>A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $330.4.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Needham has decided to maintain their Buy rating on Lululemon Athletica, which currently sits at a price target of $317.<br />
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Outperform rating for Lululemon Athletica, targeting a price of $385.<br />
&#x2A; An analyst from Telsey Advisory Group has decided to maintain their Outperform rating on Lululemon Athletica, which currently sits at a price target of $360.<br />
&#x2A; Consistent in their evaluation, an analyst from BMO Capital keeps a Market Perform rating on Lululemon Athletica with a target price of $250.<br />
&#x2A; An analyst from Baird has decided to maintain their Outperform rating on Lululemon Athletica, which currently sits at a price target of $340. </p>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Lululemon Athletica options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>


LULU

Unpacking the Latest Options Trading Trends in Lululemon Athletica

<p>Financial giants have made a conspicuous bearish move on Trade Desk. Our analysis of options history for Trade Desk (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTD#NASDAQ">TTD</a>) revealed 25 unusual trades.</p>
<p>Delving into the details, we found 44% of traders were bullish, while 48% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $244,400, and 22 were calls, valued at $1,170,194.</p>
<h3>Expected Price Movements</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $40.0 to $110.0 for Trade Desk over the last 3 months. </p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In today's trading context, the average open interest for options of Trade Desk stands at 1176.21, with a total volume reaching 2,287.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Trade Desk, situated within the strike price corridor from $40.0 to $110.0, throughout the last 30 days.</p>
<h3>Trade Desk Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310074_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th align="right"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>TTD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$11.6</td>
<td>$11.45</td>
<td>$11.5</td>
<td>$67.50</td>
<td>$178.2K</td>
<td>143</td>
<td align="right">155</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$26.05</td>
<td>$25.65</td>
<td>$25.9</td>
<td>$62.50</td>
<td>$103.6K</td>
<td>997</td>
<td align="right">0</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$10.0</td>
<td>$9.9</td>
<td>$9.96</td>
<td>$70.00</td>
<td>$99.6K</td>
<td>4.9K</td>
<td align="right">187</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$27.1</td>
<td>$26.9</td>
<td>$26.9</td>
<td>$60.00</td>
<td>$99.5K</td>
<td>1.8K</td>
<td align="right">44</td>
</tr>
<tr>
<td>TTD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$9.75</td>
<td>$9.65</td>
<td>$9.65</td>
<td>$70.00</td>
<td>$96.5K</td>
<td>4.9K</td>
<td align="right">288</td>
</tr>
</tbody>
</table>
</p>
<h3>About Trade Desk</h3>
<p>The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. It uses data in an iterative manner to optimize the performance of ad impressions purchased. The firm's platform is referred to as a demand-side platform in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising.</p>
<p>Following our analysis of the options activities associated with Trade Desk, we pivot to a closer look at the company's own performance.</p>
<h3>Where Is Trade Desk Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 5,054,279, with TTD's price up by 3.89%, positioned at $72.03.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 38 days.</li>
</ul>
<h3>Professional Analyst Ratings for Trade Desk</h3>
<p>5 market experts have recently issued ratings for this stock, with a consensus target price of $84.0.</p>
<p><strong>Unusual Options Activity Detected: Smart Money on the Move</strong></p>
<p>Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage"><strong>Click here for access</strong></a>.<br />
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $84.<br />
&#x2A; An analyst from Evercore ISI Group has elevated its stance to Outperform, setting a new price target at $90.<br />
&#x2A; In a cautious move, an analyst from Wells Fargo downgraded its rating to Equal-Weight, setting a price target of $68.<br />
&#x2A; In a cautious move, an analyst from JMP Securities downgraded its rating to Market Outperform, setting a price target of $100.<br />
&#x2A; Consistent in their evaluation, an analyst from Rosenblatt keeps a Buy rating on Trade Desk with a target price of $78. </p>
<p>Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.</p>
<p>If you want to stay updated on the latest options trades for Trade Desk, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.</p>


This Is What Whales Are Betting On Trade Desk

<p>During the last three months, 4 analysts shared their evaluations of Nu Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>), revealing diverse outlooks from bullish to bearish.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have recently evaluated Nu Holdings and provided 12-month price targets. The average target is $15.0, accompanied by a high estimate of $16.00 and a low estimate of $13.00. Marking an increase of 4.31%, the current average surpasses the previous average price target of $14.38. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310069_0.png" alt="price target chart" /></p>
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Nu Holdings. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Domingos Falavina</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$14.50</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$15.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>John Coffey</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Domingos Falavina</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$13.00</td>
<td>$14.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Nu Holdings. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Nu Holdings compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Nu Holdings's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Nu Holdings's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/NU/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Nu Holdings analyst ratings.</strong></a></p>
<h2>About Nu Holdings</h2>
<p>Nu Holdings Ltd provides digital banking services. It offers several financial services such as Credit cards, Personal accounts, Investments, Personal Loans, Insurance, Mobile payments, Business Accounts, and Rewards. The company earns the majority of its revenue in Brazil.</p>
<h3>Nu Holdings: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Nu Holdings's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>13.77%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Nu Holdings's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>24.76%</strong> net margin, the company effectively manages costs and achieves strong profitability.</p>
<p><strong>Return on Equity (ROE):</strong> Nu Holdings's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of <strong>6.86%,</strong> the company showcases efficient use of equity capital and strong financial health.</p>
<p><strong>Return on Assets (ROA):</strong> Nu Holdings's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.07%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Nu Holdings's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.04</strong>.</p>
<h2>The Significance of Analyst Ratings Explained</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Breaking Down Nu Holdings: 4 Analysts Share Their Views

<p>Dave (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) has been analyzed by 9 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">6</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $213.44, along with a high estimate of $320.00 and a low estimate of $125.00. Marking an increase of 32.37%, the current average surpasses the previous average price target of $161.25. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310060_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The analysis of recent analyst actions sheds light on the perception of Dave by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$320.00</td>
<td>$229.00</td>
</tr>
<tr>
<td>Gary Prestopino</td>
<td>Barrington Research</td>
<td>Announces</td>
<td>Outperform</td>
<td>$250.00</td>
<td>-</td>
</tr>
<tr>
<td>Hal Goetsch</td>
<td>B. Riley Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$239.00</td>
<td>$206.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$229.00</td>
<td>$202.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Raises</td>
<td>Market Outperform</td>
<td>$200.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Jacob Stephan</td>
<td>Lake Street</td>
<td>Raises</td>
<td>Buy</td>
<td>$177.00</td>
<td>$118.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$202.00</td>
<td>$145.00</td>
</tr>
<tr>
<td>Joseph Vafi</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$179.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Devin Ryan</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$125.00</td>
<td>$135.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Dave. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Dave compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Dave's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DAVE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Dave analyst ratings.</strong></a></p>
<h2>Delving into Dave's Background</h2>
<p>Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.</p>
<h3>A Deep Dive into Dave's Financials</h3>
<p><strong>Market Capitalization Analysis:</strong> The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Dave's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>46.65%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.</p>
<p><strong>Net Margin:</strong> Dave's net margin is impressive, surpassing industry averages. With a net margin of <strong>26.68%,</strong> the company demonstrates strong profitability and effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> Dave's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>15.06%</strong> ROE, the company effectively utilizes shareholder equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Dave's ROA excels beyond industry benchmarks, reaching <strong>9.37%</strong>. This signifies efficient management of assets and strong financial health.</p>
<p><strong>Debt Management:</strong> Dave's debt-to-equity ratio is below the industry average at <strong>0.38</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DAVE

Forecasting The Future: 9 Analyst Projections For Dave

<p>Across the recent three months, 10 analysts have shared their insights on CVS Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), expressing a variety of opinions spanning from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for CVS Health, presenting an average target of $79.0, a high estimate of $84.00, and a low estimate of $71.00. This upward trend is evident, with the current average reflecting a 8.97% increase from the previous average price target of $72.50.</p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310042_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive CVS Health. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Brian Tanquilut</td>
<td>Jefferies</td>
<td>Raises</td>
<td>Buy</td>
<td>$80.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$79.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$84.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Stephen Baxter</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$84.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Ben Hendrix</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$81.00</td>
<td>$74.00</td>
</tr>
<tr>
<td>Kevin Caliendo</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Andrew Mok</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$82.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Michael Ha</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$71.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>David Macdonald</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$82.00</td>
<td>$76.00</td>
</tr>
<tr>
<td>Ann Hynes</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$76.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CVS Health. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CVS Health compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts navigate through adjustments in price targets, providing estimates for CVS Health's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
<p>Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of CVS Health's market standing. Stay informed and make data-driven decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/CVS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on CVS Health analyst ratings.</strong></a></p>
<h2>Get to Know CVS Health Better</h2>
<p>CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates over 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It also operates a top-tier health insurer (acquired through Aetna) where it serves about 27 million medical members. The company's recent acquisition of Oak Street adds primary care services to the mix, which could have significant synergies with all existing business lines.</p>
<h3>CVS Health: Financial Performance Dissected</h3>
<p><strong>Market Capitalization Analysis:</strong> The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.</p>
<p><strong>Positive Revenue Trend:</strong> Examining CVS Health's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>6.96%</strong> as of 31 March, 2025, showcasing a substantial increase in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> CVS Health's net margin excels beyond industry benchmarks, reaching <strong>1.88%</strong>. This signifies efficient cost management and strong financial health.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>2.33%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> CVS Health's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of <strong>0.7%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Debt Management:</strong> CVS Health's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>1.06</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Expert Outlook: CVS Health Through The Eyes Of 10 Analysts

<p>Delek US Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DK#NYSE">DK</a>) has been analyzed by 12 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">5</td>
<td align="right">4</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $17.1, a high estimate of $23.00, and a low estimate of $11.00. Experiencing a 10.38% decline, the current average is now lower than the previous average price target of $19.08. </p>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310034_0.png" alt="price target chart" /></p>
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
<p>An in-depth analysis of recent analyst actions unveils how financial experts perceive Delek US Hldgs. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Justin Jenkins</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$23.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Underweight</td>
<td>$15.00</td>
<td>$11.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$17.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Underweight</td>
<td>$15.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$23.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Neil Mehta</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$15.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Connor Lynagh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$14.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$11.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$14.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Manav Gupta</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$13.25</td>
<td>$21.00</td>
</tr>
<tr>
<td>Justin Jenkins</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$23.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$22.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Delek US Hldgs. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Delek US Hldgs compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Delek US Hldgs's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Delek US Hldgs's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Stay up to date on Delek US Hldgs analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.</p>
<h2>Discovering Delek US Hldgs: A Closer Look</h2>
<p>Delek US Holdings Inc is an integrated energy business focused on petroleum refining, transportation and storage; wholesale crude oil, intermediate, and refined products, and convenience stores retailing. The company owns and operates independent refineries that produce a variety of petroleum products for transportation and industrial markets in the United States. It has two segments: Refining segment and Logistics segment. The logistics segment generates revenue through gathering, transporting, and storing crude oil and intermediate products, as well as by marketing, storing, and distributing refined products. The company also offers a collection of retail fuel and convenience stores operating in the Southeast region of the United States.</p>
<h3>Delek US Hldgs: Financial Performance Dissected</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Decline in Revenue:</strong> Over the 3M period, Delek US Hldgs faced challenges, resulting in a decline of approximately <strong>-15.54%</strong> in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>-6.54%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>-73.77%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of <strong>-2.55%,</strong> the company showcases effective utilization of assets.</p>
<p><strong>Debt Management:</strong> With a high debt-to-equity ratio of <strong>20.14</strong>, Delek US Hldgs faces challenges in effectively managing its debt levels, indicating potential financial strain.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p>If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


A Glimpse Into The Expert Outlook On Delek US Hldgs Through 12 Analysts

<p><strong>Houlihan Lokey's</strong> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLI#NYSE">HLI</a>) short percent of float has risen 4.81% since its last report. The company recently reported that it has <strong>950 thousand shares sold short</strong>, which is 1.96% of all regular shares that are available for trading. Based on its trading volume, <strong>it would take traders 3.33 days to cover their short positions on average.</strong></p>
<h3>Why Short Interest Matters</h3>
<p>Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.</p>
<p>Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.</p>
<p><strong>See Also:</strong> <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>List of the most shorted stocks</strong></a></p>
<h3>Houlihan Lokey Short Interest Graph (3 Months)</h3>
<p><img src="https://www.benzinga.com/files/images/story/2025/1751310028_0.png" alt="short_fig" /></p>
<p>As you can see from the chart above the percentage of shares that are sold short for Houlihan Lokey has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.</p>
<h3>Comparing Houlihan Lokey's Short Interest Against Its Peers</h3>
<p>Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.</p>
<p>According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Houlihan Lokey's peer group average for short interest as a percentage of float is 3.27%, which means the company has <strong>less</strong> short interest than most of its peers.</p>
<p>Did you know that increasing short interest can actually be <strong>bullish</strong> for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage"><strong>This post by Benzinga Money explains how you can profit from it.</strong></a></p>
<p><em>This article was generated by Benzinga's automated content engine and was reviewed by an editor.</em></p>


Short Sellers

Short Ideas

How Is The Market Feeling About Houlihan Lokey?

Press Releases

Equinor ASA: Key information relating to cash dividend for first quarter 2025

Equinor to commence second tranche of the 2025 share buy-back programme

Equinor sells the Peregrino field for USD 3.5 billion

Equinor ASA: Minutes from the annual general meeting 2025

Equinor ASA: Ex. dividend fourth quarter 2024 today – OSE

Equinor ASA: Announcement of cash dividend per share in NOK for fourth quarter 2024

Recommendation from Equinor's nomination committee

Equinor ASA: Execution of debt capital market transactions

Election to Equinor's board of directors

Equinor ASA: Share buy-back – second tranche for 2025

Chevron

Ecopetrol S.A. American Depositary Shares

Ecopetrol

Occidental Petroleum Corporation Common Stock

Occidental Petroleum

Petroleo Brasileiro S.A.- Petrobras Common Stock

Petrobras Brasileiro

Petroleo Brasileiro S.A.- Petrobras American Depositary Shares

Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares)

Comments

Equinor

Vendite allo scoperto

Equinor (NYSE:EQNR) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO